Literature DB >> 20704487

Asymptomatic pancreatic adenocarcinoma presenting as an orbital metastatic tumor.

F Y Foo1, M Lee, A Looi.   

Abstract

Although rare, orbital metastatic tumors may be the initial presentation of an asymptomatic primary carcinoma. We report a rare case, with clinicopathological correlation, of metastatic pancreatic adenocarcinoma, presenting first in the orbit with symptoms of diplopia, blurring of vision and supraorbital ache. Computed tomography and magnetic resonance imaging of the orbit showed a left solid intraconal tumor with peripheral rim enhancement. The tumor demonstrated hypointensity on both T1- and T2-weighted sequences. Excisional biopsy was performed and histopathology confirmed a metastatic adenocarcinoma. Subsequent gastrointestinal imaging and tumor markers revealed an asymptomatic pancreatic adenocarcinoma, with multiple liver metastases. Our patient developed hepatobiliary sepsis and passed away 44 days after diagnosis. This case highlights the role of early biopsy of atypical orbital tumors in the localization of an asymptomatic primary carcinoma.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20704487     DOI: 10.3109/01676830.2010.485719

Source DB:  PubMed          Journal:  Orbit        ISSN: 0167-6830


  3 in total

1.  Sclerosing Signet Ring Cell Carcinoma of the Lacrimal Gland: A Potentially New Primary Entity.

Authors:  Frederick A Jakobiec; Edith R Reshef; Lina Ma; Martin K Selig; Daniel R Lefebvre; Anna M Stagner
Journal:  Ocul Oncol Pathol       Date:  2020-02-07

2.  Metastatic pancreatic carcinoma to the orbital apex presenting as a superior divisional third cranial nerve palsy.

Authors:  Paula E Pecen; Nicholas A Ramey; Michael J Richard; M Tariq Bhatti
Journal:  Clin Ophthalmol       Date:  2012-11-23

Review 3.  Orbital metastasis as the primary manifestation of pancreatic carcinoma: a case report and literature review.

Authors:  Tatsuro Yokoyama; Aric Vaidya; Hirohiko Kakizaki; Yasuhiro Takahashi
Journal:  BMC Ophthalmol       Date:  2022-03-12       Impact factor: 2.209

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.